The objectives of this research group are focused on the following basic aspects:
Infections in transplant patients:
- To study the clinical epidemiology and risk factors of the most prevalent and serious infectious complications in solid organ and hematopoietic stem cell transplantations.
- To assess the risk factors for mortality due to an infectious cause in solid organ transplant patients.
- To develop biomarkers that will allow for determining the degree of immunosuppression of a transplant patient and their risk of developing an opportunistic infection or cancer by means of the development of clinical and analytical scores.
- To develop a laboratory of immunological techniques adapted to the evaluation of the immune response and the risk of infection by cytomegalovirus and other opportunistic microorganisms.
Infections in the oncohematological patient:
- To study the epidemiology, prevention and treatment of bacteremia caused by multidrug resistant gram-negative bacilli in hematological patients.
- To discover new methods aimed at managing invasive fungal infections.
Infections in other immunosuppressed patients:
- To assess the viral load of anelloviri (Torque-Teno virus) in patients with inflammatory joint diseases (in collaboration with the Rheumatology and Dermatology Services).
- To develop measures to prevent infections in patients receiving biological drugs.
- To study the clinical implications of candidemia.
- To develop a program aimed at controlling nosocomial infections and promoting the adequate use of antimicrobial agents (PACTA Program).